Insider Transactions in Q2 2025 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+1.25%
|
$10,000
$2.94 P/Share
|
|
Jun 30
2025
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.6%
|
$10,000
$2.94 P/Share
|
|
Apr 30
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,943
-3.51%
|
$38,829
$3.0 P/Share
|
|
Apr 30
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
10,739
-2.68%
|
$32,217
$3.0 P/Share
|
|
Apr 30
2025
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,943
-3.2%
|
$38,829
$3.0 P/Share
|
|
Apr 30
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
27,472
-4.5%
|
$82,416
$3.0 P/Share
|
|
Apr 29
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,558
-0.96%
|
$10,674
$3.23 P/Share
|
|
Apr 28
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,690
-0.36%
|
$8,070
$3.17 P/Share
|
|
Apr 28
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,364
-0.34%
|
$4,092
$3.17 P/Share
|
|
Apr 28
2025
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,644
-0.41%
|
$4,932
$3.17 P/Share
|
|
Apr 28
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
4,090
-0.67%
|
$12,270
$3.17 P/Share
|
|
Apr 23
2025
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
61,422
-3.53%
|
$122,844
$2.97 P/Share
|